FY2025 · ended Dec 31, 2025 · Revenue $137.39M, -4.0% YoY · Filed Mar 5, 2026
NRC Health (NRC) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $137.4 million and net income of $11.6 million. Free cash flow was $15.7 million. As of Sep 30, 2026 it held $3.6 million in cash and investments and $102.9 million in total debt.
Revenue (TTM)
$143.79M
+3.4% vs year-ago TTM
Net income
$11.60M
-53.2% vs prior year
Operating cash flow (TTM)
$23.77M
-7.3% vs year-ago TTM
Free cash flow (TTM)
$18.45M
+58.7% vs year-ago TTM
EPS (TTM)
$0.28
-60.4% vs year-ago TTM
Dividend per share
$0.52
+8.3% vs prior year
Shares outstanding
22.54M
-0.9% vs prior year
Net cash
$-99.27M
as of Sep 30, 2026
Operating margin
11.1%
FY 2026
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- NRC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lincoln, NE
- SEC filer status
- Accelerated filer
- SEC CIK
- 70487
- Former names
- NATIONAL RESEARCH CORP (until Mar 27, 2026)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $137.4M | $143.1M | $148.6M | $151.6M | $148.0M |
| Operating income | $22.6M | $35.2M | $40.0M | $46.5M | $50.3M |
| Net income | $11.6M | $24.8M | $31.0M | $31.8M | $37.5M |
| Diluted EPS | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 |
| Operating cash flow | $26.4M | $34.6M | $38.1M | $36.3M | $46.3M |
| Free cash flow | $15.7M | $19.2M | $22.3M | $26.4M | $40.8M |
| Total assets | $134.9M | $132.5M | $122.4M | $130.5M | $157.5M |
| Total liabilities | $120.9M | $101.3M | $73.5M | $58.4M | $72.2M |
| Stockholders' equity | $14.0M | $31.3M | $49.0M | $72.0M | $85.3M |
| Cash and investments | $4.1M | $4.2M | $6.7M | $25.0M | $54.4M |
| Total debt | $76.2M | $59.6M | $36.8M | $22.3M | $27.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 19, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 11, 2026 | Aug 7, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2026 | Jul 28, 2026 |
All 1001 NRC Health SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.